LAMTOR5 and breast carcinoma: Additionally, HBXIP upregulates TNF receptor 1 (TNFR1), forming a positive feedback loop (TNFR1/NF-κB/p38/p-STAT3/HBXIP/TNFR1) that sustains TNF-α-driven tumor progression in breast cancer [14].